Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TRPM8 | Q7Z2W7 | 3/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7731793 | 0.85 | EPHX1 (0.37) | NPC1L3MBTL1EPHX1KMT2AMEN1 | |
| SCHEMBL11291779 | 0.80 | ALDH1A1 (0.35) | NPC1L3MBTL1EPHX1KMT2AMEN1 | |
| SCHEMBL4379358 | 0.78 | NPC1 (0.35) | NPC1L3MBTL1ALDH1A1 | |
| Menthone SCHEMBL28849343 | 0.76 | NPC1 (0.42) | NPC1L3MBTL1USP2EPHX1KMT2A | |
| Menthone SCHEMBL31534032 | 0.76 | NPC1 (0.42) | NPC1L3MBTL1USP2EPHX1KMT2A | |
| Rel-Menthone SCHEMBL9996907 | 0.73 | NPC1 (0.40) | NPC1L3MBTL1USP2EPHX1KDM4E | |
| Menthone SCHEMBL9996908 | 0.73 | NPC1 (0.40) | NPC1L3MBTL1USP2EPHX1KDM4E | |
| SCHEMBL4258104 | 0.73 | NPC1 (0.37) | NPC1L3MBTL1EPHX1KMT2AMEN1 | |
| SCHEMBL1697828 | 0.73 | TRPA1 (0.35) | NPC1L3MBTL1EPHX1TRPM8TRPA1 | |
| Menthone SCHEMBL21709 | 0.71 | TLR4 (0.39) | NPC1L3MBTL1TRPM8TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7390762-B2 | Method for the preparation of high-content NaY molecular sieves synthesized from kaolin sprayed microspheres | PETROCHINA COMPANY LIMITED (CN) | 2008-06-24 | — | — | US | claimed |
| US-20060116277-A1 | Method for the preparation of high-content NaY molecular sieves synthesized from kaolin sprayed microspheres | PETROCHINA COMPANY LIMITED | 2006-06-01 | — | — | US | claimed |
| EP-3541359-B1 | TABLET COMPRISING SEPARATE BINDER AND ERYTHRITOL | FERTIN PHARMA AS (DK) | 2021-01-27 | — | — | EP | disclosed |
| US-10632076-B2 | Tablet comprising separate binder and erythritol | FERTIN PHARMA A/S (DK) | 2020-04-28 | — | — | US | disclosed |
| US-20200078308-A1 | TABLET COMPRISING SEPARATE BINDER AND ERYTHRITOL | FERTIN PHARMA A/S (DK) | 2020-03-12 | — | — | US | disclosed |
| EP-3541359-A1 | TABLET COMPRISING SEPARATE BINDER AND ERYTHRITOL | Fertin Pharma A/S (DK) | 2019-09-25 | — | — | EP | disclosed |
| WO-2018091050-A1 | TABLET COMPRISING SEPARATE BINDER AND ERYTHRITOL | FERTIN PHARMA A/S (DK) | 2018-05-24 | — | — | WO | disclosed |
| US-20180140554-A1 | TABLET COMPRISING SEPARATE BINDER AND ERYTHRITOL | FERTIN PHARMA A/S (DK) | 2018-05-24 | — | — | US | disclosed |
| WO-2013007135-A1 | EASILY ERASABLE HYDROLYTIC FADING INK AND PREPARATION METHOD THEREOF | 宁波绿拓新材料有限公司 (CN) | 2013-01-17 | — | — | WO | disclosed |
| CN-101446055-B | Matt color ink jet printer paper paint and preparation method thereof | UNIV JIANGNAN | 2010-08-25 | — | — | CN | disclosed |
| CN-101446055-A | Matt color ink jet printer paper paint and preparation method thereof | UNIV JIANGNAN (CN) | 2009-06-03 | — | — | CN | disclosed |
| US-20060116277-A1 | Method for the preparation of high-content NaY molecular sieves synthesized from kaolin sprayed microspheres | PETROCHINA COMPANY LIMITED | 2006-06-01 | — | — | US | disclosed |
| US-20060116277-A1 | Method for the preparation of high-content NaY molecular sieves synthesized from kaolin sprayed microspheres | PETROCHINA COMPANY LIMITED | 2006-06-01 | — | — | US | disclosed |
| WO-2006011046-A1 | FORMULATION FOR STIMULATING HAIR GROWTH | WARNER-LAMBERT COMPANY LLC (US) | 2006-02-02 | — | — | WO | disclosed |
| CN-1557792-A | Granulated guano phosphate fertilizer | 黄雄强 | 2004-12-29 | — | — | CN | disclosed |
| US-20030027787-A1 | Crosslinked polysaccharide, obtained by crosslinking with substituted polyethylene glycol, as superabsorbant | GROUP LYSAC INC./LYSAC GROUP INC. | 2003-02-06 | — | — | US | disclosed |
| CN-1391803-A | Rubber production promoter for rubber trees | RUBBER CULTIVATION INST CHINA (CN) | 2003-01-22 | — | — | CN | disclosed |
| CN-1391805-A | Rice coating agent and its preparing method | KUMING CITY AGRICULTURE TECHNO (CN) | 2003-01-22 | — | — | CN | disclosed |
| CN-1332058-A | Welding rod resulting in high fatigue strength of welded joint | UNIV TIANJIN (CN) | 2002-01-23 | — | — | CN | disclosed |
| US-5059614-A | NOVEL ISOXAZOLE AND ISOXAZOLINE COMPOUNDS WITH ANTICONVULSANT ACTIVITY PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITION CONTAINING THEM | NOVAPHARME (FR) | 1991-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030027787-A1 | Crosslinked polysaccharide, obtained by crosslinking with substituted polyethylene glycol, as superabsorbant | CLTB, SI, CLTA | NPC1 3471/4885L3MBTL1 1726/4885USP2 424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.